Abexinostat
CAS: 783355-60-2
Ref. TM-T0431
1mg | 39.00 € | ||
2mg | 50.00 € | ||
5mg | 78.00 € | ||
10mg | 107.00 € | ||
25mg | 178.00 € | ||
50mg | 319.00 € | ||
100mg | 501.00 € | ||
1ml*10 (DMSO) | 78.00 € |
Product Information
- CRA 24781, PCI24781, PCI-24781, PCI 24781, CRA 024781
- 2-Benzofurancarboxamide, 3-[(dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-
- 3-[(Dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide
- Brd K12867552
- Cra 024781
- Cra 24781
- Pci 24781
- Thm-I 94
PCI-24781 (Abexinostat (PCI24781)) is a new pan-HDAC inhibitor mainly targeting HDAC1 (Ki: 7 nM), also have moderate inhibitory for HDACs 2, 3, 6, and 10 and greater than 40-fold selectivity against HDAC8. Phase 1/2.
Chemical properties
Technical inquiry about: TM-T0431 Abexinostat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.